MedPath

Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

Phase 2
Withdrawn
Conditions
Root Canal Therapy
Interventions
Drug: Collagen-hydroxyapatite scaffold (Syn-Oss)
Drug: Collagen Scaffold (Colla-Plug)
Registration Number
NCT03613090
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

The purpose of this investigation is to assess the use of a novel scaffold (an FDA-approved collagen-hydroxyapatite material called Syn-Oss) for regeneration of pulp tissues versus the use of a traditional scaffold (blood clot).

Detailed Description

Regeneration of pulp tissues in teeth with immature roots is a new concept based on historical limited success using calcium hydroxide dressings placed into debrided pulp spaces. Obtaining stem cells from the apical papilla (SCAP cells), which are present at the base of all teeth, but are most accessible in teeth with immature apices, greatly enhances clinical success. Current therapies lack ideal messenger chemicals and scaffolds to optimize results.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Single root canal space apparent on a standard dental periapical radiograph
  2. Immature tooth apex width at least 1.1mm in diameter as measured from the radiograph
  3. No history of antibiotic drug allergy
  4. Necrotic pulp as demonstrated by coronal discoloration.
  5. Periapical radiolucency
  6. Negative pulp sensibility tests
  7. Other standard clinical means of assessing pulp vitality status
Read More
Exclusion Criteria
  1. Any patients having an American Association of Anesthesiologists 4 health classification will be excluded.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Collagen-hydroxyapatite Scaffold (Syn-Oss)Collagen-hydroxyapatite scaffold (Syn-Oss)Placement of a collagen-hydroxyapatite scaffold (Syn-Oss), placement of a tricalcium silicate barrier (mineral trioxide aggregate), placement of a composite occlusal restoration (standard dental material).
Collagen Scaffold (Colla-Plug)Collagen Scaffold (Colla-Plug)Placement of a collagen scaffold (Colla-Plug) over a blood clot, placement of a tricalcium silicate barrier (mineral trioxide aggregate), placement of a composite occlusal restoration (standard dental material). The Colla-Plug material is placed adjacent to the blood clot that has formed inside the root canal space. It act as a matrix for the subsequent placement of the mineral trioxide aggregate material. It has been used as the standard of care in regenerative endodontics since 2004.
Primary Outcome Measures
NameTimeMethod
Observation 2 - Increase in dentin wall thickness. It is noted that minimal change is expected over the course of this short-term study.Months 3-6, patient recruitment and revascularization surgery in Department of Endodontics

Grade 1 = dentin wall thickness increased by \> 1mm Grade 2 = dentin wall thickness \< 1mm

Observation 1-Radiodensity at apex @ 1mm from root vertexMonth 0-3, Institutional Review Board proposal and approval

Grade 1 = no disruption of apical anatomy Grade 2 = Periodontal ligament (PDL) width double thickness, with intact lamina dura Grade 3 = break in lamina dura

Observation 4 - Periradicular statusMonth 13-15, data analysis and manuscript preparation

Grade 1 = no periradicular radiolucency Grade 2 = periradicular radiolucency 0-1 mm in diameter Grade 3 = periradicular radiolucency \> 1 mm in diameter

Observation 3 - Increase in root length, in mm.Month 6-12, clinical and radiographic recall and assessment

Grade 1 = root length increased \> 1 mm Grade 2 = root length increased 0-1 mm Grade 3 = root length shorter than pre-op

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath